Patent · US Active

Carbamate derivatives

US9326976B2 · kind B2 · utility

1Cited by
1References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 28, 2015
Grant dateMay 3, 2016
Priority date—
Expiry dateMay 28, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D453/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I) defined herein are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of diseases of the respiratory tract.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.